Elziverine

CAS No. 95520-81-3

Elziverine( —— )

Catalog No. M36165 CAS No. 95520-81-3

Elziverine is an orally available small molecule calmodulin antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 426 Get Quote
5MG 655 Get Quote
10MG 934 Get Quote
25MG 1343 Get Quote
50MG 1812 Get Quote
100MG 2385 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Elziverine
  • Note
    Research use only, not for human use.
  • Brief Description
    Elziverine is an orally available small molecule calmodulin antagonist.
  • Description
    Elziverine is an orally available small molecule calmodulin antagonist.Elziverine in vitro treatment inhibited Ca-loading-induced acanthocyte formation in SHRSP, WKY, and Wistar rats in a concentration-dependent manner.Elziverine can be used for the treatment of neurological disorders, and may be used for the study of cognitive disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    CaMK
  • Recptor
    CaMK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    95520-81-3
  • Formula Weight
    543.65
  • Molecular Formula
    C32H37N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=1C2=C(C(CN3CCN(CC3)C4=C(OC)C=CC=C4)=CN1)C=C(OC)C(OC)=C2)C5=CC(OC)=C(OC)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • KN-93 Phosphate B

    KN-93 (Phosphate) can competitively block the binding of calmodulin to the corresponding kinase. It is a calcium/calmodulin-dependent kinase II (CaMKII) inhibitor with a Ki of 370 nM.

  • Melatonine

    Melatonin is a MT receptor agonist, used as a dietary supplement.

  • Autocamtide-2-relate...

    CaM kinase II inhibitor; enhanced cell permeable derivative of Autocamtide-2-related inhibitory peptide. Pretreatment blocks reinstatement of morphine-seeking behavior in vivo.